JPWO2023041622A5 - - Google Patents
Info
- Publication number
- JPWO2023041622A5 JPWO2023041622A5 JP2024512096A JP2024512096A JPWO2023041622A5 JP WO2023041622 A5 JPWO2023041622 A5 JP WO2023041622A5 JP 2024512096 A JP2024512096 A JP 2024512096A JP 2024512096 A JP2024512096 A JP 2024512096A JP WO2023041622 A5 JPWO2023041622 A5 JP WO2023041622A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- seq
- activating anti
- antibody
- btn3a
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21306272 | 2021-09-15 | ||
| EP21306272.2 | 2021-09-15 | ||
| PCT/EP2022/075608 WO2023041622A1 (en) | 2021-09-15 | 2022-09-15 | Selection of responders for anti-btn3a treatment |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024533067A JP2024533067A (ja) | 2024-09-12 |
| JPWO2023041622A5 true JPWO2023041622A5 (https=) | 2025-09-24 |
| JP2024533067A5 JP2024533067A5 (https=) | 2025-09-24 |
Family
ID=77998935
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024512096A Pending JP2024533067A (ja) | 2021-09-15 | 2022-09-15 | 抗ｂｔｎ３ａ治療に対するレスポンダーの選択 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20230227558A1 (https=) |
| EP (1) | EP4401837A1 (https=) |
| JP (1) | JP2024533067A (https=) |
| CN (1) | CN118475611A (https=) |
| TW (1) | TW202313695A (https=) |
| WO (1) | WO2023041622A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HRP20260034T1 (hr) * | 2018-08-01 | 2026-02-27 | Imcheck Therapeutics | Anti-btn3a antitijela i njihova upotreba u liječenju raka ili infektivnih poremećaja |
| JP2026506893A (ja) * | 2023-02-23 | 2026-02-27 | イムチェック セラピューティクス エスエーエス | Ｂｔｎ３ａ活性化抗体と免役チェックポイント阻害剤の併用 |
| TW202506731A (zh) * | 2023-04-27 | 2025-02-16 | 法商感應檢查療法公司 | 治療多重抗藥性細菌感染之方法 |
| WO2024251981A1 (en) * | 2023-06-09 | 2024-12-12 | Umc Utrecht Holding B.V. | Detecting and/or modulating susceptibility to btn2a1 and/or btn3a1 targeting therapeutics |
| WO2024261239A1 (en) * | 2023-06-23 | 2024-12-26 | Imcheck Therapeutics | Bispecific antibodies targeting btn3a and the pd-1/pd-l1 inhibitory axis |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0368684B2 (en) | 1988-11-11 | 2004-09-29 | Medical Research Council | Cloning immunoglobulin variable domain sequences. |
| WO2012080769A1 (en) | 2010-12-15 | 2012-06-21 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Anti-cd277 antibodies and uses thereof |
| HRP20260034T1 (hr) | 2018-08-01 | 2026-02-27 | Imcheck Therapeutics | Anti-btn3a antitijela i njihova upotreba u liječenju raka ili infektivnih poremećaja |
-
2022
- 2022-09-14 TW TW111134773A patent/TW202313695A/zh unknown
- 2022-09-15 EP EP22801343.9A patent/EP4401837A1/en active Pending
- 2022-09-15 WO PCT/EP2022/075608 patent/WO2023041622A1/en not_active Ceased
- 2022-09-15 CN CN202280062098.6A patent/CN118475611A/zh active Pending
- 2022-09-15 JP JP2024512096A patent/JP2024533067A/ja active Pending
-
2023
- 2023-03-14 US US18/183,588 patent/US20230227558A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024037894A5 (https=) | ||
| JP2021184721A5 (https=) | ||
| JP2019107018A5 (https=) | ||
| JP2023027199A5 (https=) | ||
| JP2020019787A5 (https=) | ||
| JP2021528423A5 (https=) | ||
| RU2018146886A (ru) | Пути терапевтического применения ингибитора c-raf | |
| JP2019519499A5 (https=) | ||
| JP2020182492A5 (https=) | ||
| JP2019515008A5 (https=) | ||
| JP2018534933A5 (https=) | ||
| HRP20230517T1 (hr) | Kombinacija anti-pd-1 antitijela i radijacijske terapije za liječenje raka | |
| JP2020508317A5 (https=) | ||
| JP2017514795A5 (https=) | ||
| JPWO2020132066A5 (https=) | ||
| WO2019072220A1 (zh) | Pd-1抗体和表观遗传调节剂联合在制备治疗肿瘤的药物中的用途 | |
| JP2019524820A5 (https=) | ||
| JPWO2019246356A5 (https=) | ||
| JPWO2023041622A5 (https=) | ||
| JPWO2020160527A5 (https=) | ||
| JP2020535180A5 (https=) | ||
| FI3880186T3 (fi) | PD-1-inhibiittoreiden intralesionaalinen antaminen ihosyövän hoitamiseksi | |
| JPWO2022256559A5 (https=) | ||
| JPWO2020096915A5 (https=) | ||
| JPWO2021087016A5 (https=) |